This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • HIV infection
  • /
  • Safety and immunogenicity of two heterologous HIV ...
Journal

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

Read time: 2 mins
Published:30th Sep 2020
Author: Baden LR, Stieh DJ, Sarnecki M, Walsh SR, Tomaras GD, Kublin JG et al.
Source: The Lancet HIV
Availability: Free full text
Ref.:Lancet HIV. 2020 Oct;7(10):e688-e698.
DOI:10.1016/S2352-3018(20)30229-0.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest